Cellular response DSIP modulates the sleep-wake cycle by influencing cortisol rhythms, promoting delta-wave sleep, and lowering stress hormones
Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5
Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects
Early clinical trials suggest it may represent a groundbreaking advancement in obesity and diabetes treatment
The EECs are the main cells involved in the production and secretion of a variety of hormones and signaling molecules in the GBA
The intranasal GHK-Cu treatment was found to delay cognitive impairment, reduce amyloid plaques, and lower inflammation levels in the frontal cortex and hippocampus .37 Randomized controlled trials in human patients are needed to confirm the benefit of GHK-Cu for cognitive decline and Alzheimers disease as well as to evaluate safe and effective human dosing (the human dose equivalent of 15mg/kg in mice would be ~1.2mg/kg, though data on this or any other dosing nasally in humans is not currently available), but preliminary animal trials are promising